Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Male pattern baldness may predict prostate cancer risk.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.

Hair loss in young men in Central India is linked to severe heart disease.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Gene variation affects prostate issues and hair loss.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Certain natural compounds called terpenes may help prevent prostate cancer.

Diseases have a big social impact in Nordic countries, affecting healthcare decisions.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.